 |
|
|
 |
Breast cancer patients switched to Aromasin were more likely to remain cancer free, new study shows
Post-menopausal breast cancer patients who switched from tamoxifen to Aromasin(R) (exemestane tablets) had a significantly reduced chance of recurrence and increased disease-free survival compared to patients who remained on tamoxifen.
more
|
|
As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
As reported yesterday by the Centers for Disease Control and Prevention, an estimated 129.6 million Americans, or 64 percent of the population, are overweight or obese. As obesity in America has become an epidemic over the past decade, the rate of type 2 diabetes, which is closely linked to obesity, has skyrocketed. more
|
|
Breast self examination increases women's concerns but has no effect on mortality
Breast self-examination (BSE) should not be seen as a cheaper alternative to mammography, and people who still advocate it as an effective way of reducing breast cancer mortality are doing women a disservice, a scientist will say at the 4th European Breast Cancer Conference next week (Tuesday 16 March).
more
|
|
|
|
Experimental smallpox vaccine protects against monkeypox in nonhuman primates
Scientists evaluating MVA, a potential safer replacement for the licensed Dryvax smallpox vaccine, have shown that MVA elicits an immune response comparable to that of Dryvax in a monkeypox model of human disease. In addition, MVA protected nonhuman primates exposed to lethal doses of the monkeypox virus.
more
|
|
Stress hormones and heart failure
A hormone that helps the body adapt to stress may provide a key to designing treatments for congestive heart failure, according to a study by researchers at the Salk Institute for Biological Studies and the University of California, San Diego (UCSD) School of Medicine. more
|
|
Can exercise before diving prevent decompression sickness?
Nowadays, scuba diving involves millions of people worldwide. Decompression sickness following diving is initiated by the formation of gas bubbles in tissue and blood.
more
|
|
Researchers begin promising new trial to fight colorectal cancer
New York University School of Medicine investigators are leading a national study, called TREE-2, which will evaluate the safety and efficacy of three regimens of Eloxatin™ plus fluoropymidine, plus Avastin™ as first-line treatment of patients with advanced colorectal cancer. Two hundred and ten patients will be enrolled at 80 sites in the United States. more
|
|
|
